newsfilter
← Latest News
PR Newswire·

Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain

MMSI
  • Medtronic plc has entered into an exclusive distribution agreement with Merit Medical Systems, Inc. to offer the FDA-cleared ViaVerte™ basivertebral nerve ablation (BVNA) system.
  • ViaVerte™ is the first & only BVNA system featuring a physician-controlled steerable mechanism designed for precise targeting of the basivertebral nerve.
  • The agreement expands Medtronic's pain interventions portfolio to treat chronic vertebrogenic lower back pain caused by damaged vertebral endplates.
  • The minimally invasive ViaVerte™ procedure is a same-day outpatient treatment scheduled to become available later this year.
  • This deal builds upon an existing relationship where Merit supplies Medtronic's Kyphon™ Xpander™ Inflation Syringes & Kyphon™ KyphoFlex™ unipedicular steerable balloon catheter.
  • Medtronic's broader pain therapy portfolio includes spinal cord stimulation, vertebral augmentation, nerve ablation, bone tumor ablation, & targeted drug delivery.
  • According to the American Chronic Pain Association, an estimated one in three Americans suffers from some type of chronic pain.